1. Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs non-coronary disease. Eur Heart J 2010; 32: 404-11.
2. Wu AHB, Feng YJ. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur J Cardiol 1998; 19: 25-9.
3. IFCC. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer. 2012. Available from IFCC Troponin Tables ng/l Update December 2012. pdf. Accessed on 23 May, 2014.
4. Apple FS, Collinson PO. IFCC Task Force on Clinical Application of Cardiac Biomarkers. Analytical Characteristics of high sensitivity cardiac troponin assays. Clin Chem 2011; 58: 54-61.
5. Lippi G, Montagnana M, Aloe R, Cervellin G. High sensitive troponin immunoassays: navigating between the Scylla and charybdis. Adv Clin Chem 2012; 58: 1-29.
6. de Lemos J. A. Increasingly sensitive Assay for Cardiac Troponins. JAMA 2013; 309 (21): 2262-9.
7. Javed U, Aftab W, Ambrose JA, et al. Frequency of elevated troponin and diagnosis of acute myocardial infarction. Am J Cardiol 2009; 104: 9-13.
8. Mueller M, Vafaie M, Biener M. Cardiac troponin T. Circ J 2013; 77 (7): 1653-61.
9. Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: Insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011; 97: 823-31.
10. Pascual-Figal DA, Casas T, Ordonez-Lianes J, et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 2012; 163(6); 1002-10.
11. Rubin J, Matsushita K, Ballantyne CM, et al. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol 2012; 59(5): 484-9.
12. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. Suppl. 2013; 3: 1-150.
13. Lankeit M, Friesen D, Aschoff J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J 2010; 31: 1836-44.
14. Masson S, Latini R, Mureddu GF, et al. High — sensitivity cardiac troponin T for detection on subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 2013; 273(3): 306-17.
15. Ndrepepa G, Braun S, Schulz S, et al. High sensitivity troponin T level and angiographic severity of coronary artery disease. Am J Cardiol 2011; 108(5): 639-43.
16. Ucar H, Gur M, Seker T, et al. High –Sensitivity Cardiac Troponin T is Associated with SYNTAX Score and Diabetes Mellitus in Patients with stable Coronary Artery Disease. J Clin Exp Cardiolog 2013; 4: 263.
17. Korosoglou G, Lehrke S, Mueller D, et al. Determinants of troponin release in patients with stable coronary artery disease: Insights from CT angiography Heart 2011; 97: 823-31.
18. Shah AS, Langrish SP, Li X, et al. Cardiac troponin reflect silent myocardial ischemia in patients with stable coronary artery disease. J Am Coll Cardiol 2012; 59: E 1415.
19. Ahmed W, Schlett CL, Uthamalingam S, et al. Single Resting hsTnT Level Predicts Abnormal Myocardial Stress Test in Acute Chest Pain Patients With Normal Initial Standard Troponin. JACC Cardiovase Imaging 2013; 6(1): 72-82.
20. Sabatine MS, Morrow DA, deLemos JA, et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 2009; 30(2): 162-9.
21. Roysland R, Kravdal G, Hoiseth AD, et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 Study. Clin Sci 2012; 122(12): 599-606.
22. Jaffe AS, Wu AHB. Troponin Release-Reversible or Irreversible Injury? Schould We Care? Сlinical chemistry 2012; 58: 1148-50.
23. Оmland T, de Lemos JA, Sabatine MS, et al. Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009; 361(26): 2538-47.
24. Omland T, Pfeffer MA, Solomon SD, et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013; 61(12): 1240-9.
25. Shah AS, Anand A, Sandoval Y, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndromes: a cohort study. Lancet 2015; Oct 7.
26. Melki D, Lugnegard J, Alfredsson J, et al. Implication of introducing high-sensitivity cardiac troponin T into clinical practice: data from the SWEDEHEART registry. J Am Coll Cardiol 2015; 65: 1655-64.
27. Beatty AL, Ku IA, Christenson RH, et al. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern Med 2013; 173(9): 763-9.
28. Koenig W, Breitling LP, Hahmann H, et al. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chemistry 2012; 58(8): 1215-24.